{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T03:03:56Z","timestamp":1793070236197,"version":"4.5.0"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T00:00:00Z","timestamp":1733875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Current guidelines recommend that hyperthyroid patients should be rendered euthyroid prior to surgical procedures. These guidelines rely heavily on the use of ATDs as the primary medication, and do not give recommendations for patients who have contraindications to ATDs, or for whom standalone ATD treatment is inadequate.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives<\/jats:title><jats:p>To evaluate the efficacy and safety of adjunctive pharmacological therapy and\/or therapeutic plasma exchange (TPE) in the perioperative management of patients with thyrotoxicosis who were intolerant to ATD or for whom standalone ATD therapy was inadequate to achieve euthyroidism prior to surgery.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A comprehensive search of MEDLINE, Google Scholar, Embase and CENTRAL up to 31 December 2023 retrieved 12,876 records. After screening titles, abstracts and full manuscripts, 16 reports were enrolled. The study quality was evaluated using the Newcastle-Ottawa Scale (NOS).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Patients were primarily female (78.5%), aged between 35 and 52 years. The predominant thyroid condition was Graves\u2019 disease (89.7%). Majority underwent thyroidectomy (99.3%). Patients treated pre-operatively with 2nd line pharmacotherapy with\/without therapeutic plasma exchange (TPE) underwent surgery safely with no reports of perioperative thyroid storm. Pre-operative treatment achieved mean percentage reduction of free thyroxine and free triiodothyronine levels of 52.6 \u00b1 8.2% and 68.1 \u00b1 9.3% respectively. One study reported a patient who suffered from myocardial infarction and tachyarrhythmia and subsequently demised.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Preoperative management of hyperthyroidism with second line pharmacotherapy and\/or TPE can be effectively and safely implemented in patients with intolerance to or ineffective treatment with ATDs. The treatment modalities were generally safe, though some complications were observed.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2024.1498014","type":"journal-article","created":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T04:37:35Z","timestamp":1733891855000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Management of perioperative thyrotoxicosis \u2013 what to do when standard therapy is contraindicated or fails?"],"prefix":"10.3389","volume":"15","author":[{"given":"Kristy","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trilene","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jielin","family":"Yew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiaw-Ling","family":"Chng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,12,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1507\/endocrj.42.697","article-title":"A hyperthyroid patient with Graves\u2019 disease who was strongly resistant to methimazole: investigation on possible mechanisms of the resistance","volume":"42","author":"Li","year":"1995","journal-title":"Endocr J"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2008.0094","article-title":"Dramatic response to cholestyramine in a patient with Graves\u2019 disease resistant to conventional therapy","volume":"18","author":"Sebasti\u00e1n-Ochoa","year":"2008","journal-title":"Thyroid"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.72.850.489","article-title":"Treatment of thyrotoxicosis resistant to carbimazole with corticosteroids","volume":"72","author":"Jude","year":"1996","journal-title":"Postgrad Med J"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-41-2-354","article-title":"Acute effects of corticosteroids on thyroid activity in Graves\u2019 disease","volume":"41","author":"Williams","year":"1975","journal-title":"J Clin Endocrinol Metab"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2009.06.002","article-title":"Lithium and thyroid","volume":"23","author":"Lazarus","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-008-9107-5","article-title":"Low doses of cholestyramine in the treatment of hyperthyroidism","volume":"34","author":"Kaykhaei","year":"2008","journal-title":"Endocrine"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1089\/thy.1991.1.273","article-title":"Propranolol and thyroid hormone metabolism","volume":"1","author":"Wiersinga","year":"1991","journal-title":"Thyroid"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2016.0229","article-title":"2016 American thyroid association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis","volume":"26","author":"Ross","year":"2016","journal-title":"Thyroid"},{"key":"B9","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/jca.22043","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice \u2013 evidence-based approach from the writing committee of the american society for apheresis: the ninth special issue","volume":"38","author":"Connelly-Smith","year":"2023","journal-title":"J Clin Apheresis"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-018-1661-x","article-title":"Therapeutic plasmapheresis in thyrotoxic patients","volume":"62","author":"Simsir","year":"2018","journal-title":"Endocrine"},{"key":"B11","doi-asserted-by":"publisher","first-page":"102744","DOI":"10.1016\/j.transci.2020.102744","article-title":"The role of therapeutic plasmapheresis in patients with hyperthyroidism","volume":"59","author":"Ozdemir Baser","year":"2020","journal-title":"Transfus Apher Sci"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2020.05.004","article-title":"Perioperative evaluation and management of endocrine disorders","volume":"95","author":"Himes","year":"2020","journal-title":"Mayo Clin Proc"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.4103\/ijem.ijem_273_22","article-title":"Perioperative management for non-thyroidal surgery in thyroid dysfunction","volume":"26","author":"Malhotra","year":"2022","journal-title":"Indian J Endocrinol Metab"},{"key":"B14","unstructured":""},{"key":"B15","article-title":"Comparison of urgent and elective thyroidectomy complications in Graves\u2019 disease","volume":"92","author":"Kartal","year":"2022","journal-title":"Ann Ital Chir"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-019-05125-5","article-title":"Outcomes after urgent thyroidectomy following rapid control of thyrotoxicosis in graves\u2019 Disease are similar to those after elective surgery in well-controlled disease","volume":"43","author":"Ali","year":"2019","journal-title":"World J Surg"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1530\/EC-17-0025","article-title":"Rescue pre-operative treatment with Lugol\u2019s solution in uncontrolled Graves\u2019 disease","volume":"6","author":"Calissendorff","year":"2017","journal-title":"Endocr Connect"},{"key":"B18","doi-asserted-by":"publisher","first-page":"w14243","DOI":"10.4414\/smw.2016.14243","article-title":"Rapid preoperative blockage of thyroid hormone production \/ secretion in patients with Graves\u2019 disease","volume":"146","author":"Fischli","year":"2016","journal-title":"Swiss Med Wkly"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-031981","article-title":"Rapid preoperative preparation for severe hyperthyroid Graves\u2019 disease","volume":"89","author":"Panzer","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1159\/000112975","article-title":"The use of lithium carbonate in the preparation for definitive therapy in hyperthyroid patients","volume":"17","author":"Akin","year":"2008","journal-title":"Med Princ Pract"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-021-02975-9","article-title":"Efficacy of preoperative therapeutic plasma exchange in patients with hyperthyroidism and factors affecting the number of sessions","volume":"76","author":"Durmu\u015f","year":"2022","journal-title":"Endocrine"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-022-01897-1","article-title":"Therapeutic plasma exchange in hyperthyroidism prior to surgery","volume":"46","author":"Kirkizlar","year":"2023","journal-title":"J Endocrinol Invest"},{"key":"B23","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1159\/000507019","article-title":"Therapeutic plasma exchange in refractory hyperthyroidism","volume":"10","author":"Sa\u00efe","year":"2021","journal-title":"Eur Thyroid J"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.4183\/aeb.2021.346","article-title":"Preoperative therapeutic plasma exchange and surgical treatment in thyrotoxicosis patients: A single-centre retrospective cohort study","volume":"17","author":"Yabanoglu","year":"2021","journal-title":"Acta Endocrinol (Buchar)"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.4236\/ojemd.2020.1011014","article-title":"Resistance to anti-thyroid drugs in graves\u2019 Disease: clinical-biological characteristics and alternative therapy in tropical area","volume":"10","author":"Diack","year":"2020","journal-title":"Open J Endocrine Metab Diseases"},{"key":"B26","doi-asserted-by":"publisher","first-page":"0300060521996192","DOI":"10.1177\/0300060521996192","article-title":"Very rare case of Graves\u2019 disease with resistance to methimazole: a case report and literature review","volume":"49","author":"Mori","year":"2021","journal-title":"J Int Med Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"649084","DOI":"10.4061\/2011\/649084","article-title":"Resistant thyrotoxicosis in a patient with graves disease: A case report","volume":"2011","author":"Saleem","year":"2011","journal-title":"J Thyroid Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1995.tb02030.x","article-title":"Response to methimazole in Graves\u2019 disease. The European Multicenter Study Group","volume":"43","author":"Benker","year":"1995","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2001.117412","article-title":"Identification of functionally variant MDR1 alleles among European Americans and African Americans","volume":"70","author":"Kim","year":"2001","journal-title":"Clin Pharmacol Ther"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1159\/000339473","article-title":"Greater efficacy of total thyroidectomy versus radioiodine therapy on hyperthyroidism and thyroid-stimulating immunoglobulin levels in patients with graves\u2019 Disease previously treated with antithyroid drugs","volume":"1","author":"Kautbally","year":"2012","journal-title":"Eur Thyroid J"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jss.2014.03.034","article-title":"Identifying Predictors Of A Difficult Thyroidectomy","volume":"190","author":"Mok","year":"2014","journal-title":"J Surg Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1177\/2151458513504215","article-title":"Preoperative thyroid dysfunction predicts 30-day postoperative complications in elderly patients with hip fracture","volume":"4","author":"Ling","year":"2013","journal-title":"Geriatr Orthop Surg Rehabil"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1159\/000490384","article-title":"2018 European thyroid association guideline for the management of graves\u2019 Hyperthyroidism","volume":"7","author":"Kahaly","year":"2018","journal-title":"Eur Thyroid J"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aew182","article-title":"Preoperative heart rate and myocardial injury after non-cardiac surgery: results of a predefined secondary analysis of the VISION study","volume":"117","author":"Abbott","year":"2016","journal-title":"Br J Anaesth"},{"key":"B35","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jss.2019.07.029","article-title":"Assessing american thyroid association guidelines for total thyroidectomy in graves\u2019 Disease","author":"Akram","year":"2020","journal-title":"J Surg Res"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2019.0036","article-title":"Antigen-specific immunotherapy with thyrotropin receptor peptides in graves' hyperthyroidism: a phase I study","volume":"29","author":"Pearce","year":"2019","journal-title":"Thyroid"},{"key":"B37","doi-asserted-by":"publisher","first-page":"dgz013","DOI":"10.1210\/clinem\/dgz013","article-title":"A novel anti-CD40 monoclonal antibody, iscalimab, for control of graves hyperthyroidism-A proof-of-concept trial","volume":"105","author":"Kahaly","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B38","unstructured":"ISRCTN - ISRCTN11659633: Safety, tolerability, pharmacokinetics, and pharmacodynamics of single\/multiple doses of IMVT-1402 in healthy participants and participants with autoimmune diseases2024"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1498014\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T04:37:41Z","timestamp":1733891861000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1498014\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,11]]},"references-count":38,"alternative-id":["10.3389\/fendo.2024.1498014"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2024.1498014","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,11]]},"article-number":"1498014"}}